Implementing Pharmacogenomics into Clinical Practice Certificate Program (2nd Edition)

This course is approved by the Florida Board of Pharmacy for 28.0 general recertification hours.

Objectives

At the completion of this activity, the participant will be able to:

• Describe the contribution of genetics to interindividual variability in drug metabolizing enzymes and predicting patient’s response to therapy.
• Apply information from pharmacogenomic resources, databases, and guidelines to clinical practice and patient case scenarios.
• Educate patients and providers in the utility and implications of pharmacogenomic testing and resulting information.
• Utilize pharmacogenomic information to develop treatment recommendations in certain disease states including cardiovascular, cancer, and psychiatric conditions.
• Create a plan to implement pharmacogenomic information and clinical decision support tools into electronic health records in various practice settings.

Program Overview

Module 1: Introduction to Pharmacogenomics

This content will provide the foundational knowledge needed to guide the learner through the certificate.

Module 2: Science of Pharmacogenomics

This module will define pharmacogenetics and pharmacogenomics and outline the benefits of genomic medicine. Content will focus specifically on pharmacogenomics of drug metabolism and drug transporters.

Module 3: Fundamentals of Clinical Pharmacogenomics and Pharmacogenomic Testing

This module will define the CPIC guidelines and explain how they can be used by clinicians to make specific prescribing decisions for patient care when genetic information is available.  It will also review available evidence sources for pharmacogenomic recommendations and explain strategies for using the Pharmacogenomics Knowledgebase (PharmGKB) to assess the usefulness and practical applications of pharmacogenomic information in the clinical setting. Content will also review clinical laboratory and direct-to-consumer pharmacogenomic testing.

Module 4: Cardiology and Oncology

This module will discuss clinical implications of genetic variability in oncology pharmacotherapy and patient-specific, genetic, and other factors that inform drug therapy changes in oncology.  It will also summarize clinical implications of genetic variability on cardiovascular drug response and explain factors influencing the clinical implementation of genotyping to help guide cardiovascular drug therapy.

Module 5:  Pain Management, Psychiatry, and ADRs

This module will identify medications affected by multiple genes and summarize the clinical implications of genetic variability in pain management and psychiatry. Content will specifically focus on pain management, adverse drug reactions/hypersensitivity, and psychiatry pharmacogenetics.

Module 6: Clinical Implementation of Pharmacogenomics

This module will summarize how to develop a clinical pharmacogenomic service, manage testing and reimbursement for pharmacogenetic results, and design electronic and written documentation. Content will focus on clinical decision support, patient and provider education, and challenges and solutions for implementing pharmacogenomics in diverse practice settings.

Requirements for Successful Course Completion

In order to earn credit for this course, participants must complete all course case studies and quizzes with a score of 70% or higher. Two chances to pass each quiz/assessment will be given. If a passing score is not earned by the second attempt, the participant must re-enroll in the course. Upon successful completion of all coursework, participants must complete a course evaluation form.

Upon successful completion of the course, participants will be awarded a certificate of completion.

Course Access

To access your course after enrollment, please click the link below.

http://elearning.ufl.edu/

Click the blue “Log in to Continuing Education” button and enter your login credentials. You should then see your course on the Canvas dashboard or by clicking Courses>All Courses.

Disclosure Statement

The following speakers, reviewers, and planning committee members have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

D. Max Smith, Pharm.D., BCPS

Clinical Pharmacogenomics Specialist at MedStar Health
Assistant Professor at Georgetown University Medical Center

Jamie Wilkey, Pharm.D.

Founder, PGx Consulting Confidence Academy
Chief Executive Officer, Arches Health, LLC

Amanda Elchynski, Pharm.D., BCPS

Pharmacogenomics Clinical Coordinator at Arkansas Children’s Hospital

Scott Mosley, Pharm.D.

Pharmacogenomics Fellow
Department of Pharmacotherapy and Translational Research
Center for Pharmacogenomics

Additional Resources

Please review the resources below before registering for the course.

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.